Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema

Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema

Diabetic macular oedema (DMO) is one of the leading causes of vision loss associated with diabetic retinopathy (DR). New insights in managing this condition have changed the paradigm in its treatment, with intravitreal injections of antivascular endothelial growth factor (anti-VEGF) having become th...

Full description

Bibliographic Details
Main Authors: Milagros Mateos-Olivares, Luis García-Onrubia, Fco. Javier Valentín-Bravo, Rogelio González-Sarmiento, Maribel Lopez-Galvez, J. Carlos Pastor, Ricardo Usategui-Martín, Salvador Pastor-Idoate
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cells
Subjects:
diabetic macular oedema
diabetic retinopathy
macular oedema
rho-associated kinases
Online Access:https://www.mdpi.com/2073-4409/10/7/1683

Internet

https://www.mdpi.com/2073-4409/10/7/1683

Similar Items